Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Other Non-Current Assets (2023 - 2025)

Immunome (IMNM) has disclosed Other Non-Current Assets for 3 consecutive years, with $4.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 3.99% year-over-year to $4.6 million, compared with a TTM value of $4.6 million through Dec 2025, up 3.99%, and an annual FY2025 reading of $4.6 million, up 3.99% over the prior year.
  • Other Non-Current Assets was $4.6 million for Q4 2025 at Immunome, up from $210000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $4.6 million in Q4 2025 and bottomed at $100000.0 in Q1 2023.
  • Average Other Non-Current Assets over 3 years is $850666.7, with a median of $100000.0 recorded in 2023.
  • Peak annual rise in Other Non-Current Assets hit 4311.0% in 2024, while the deepest fall reached 0.0% in 2024.
  • Year by year, Other Non-Current Assets stood at $100000.0 in 2023, then soared by 4311.0% to $4.4 million in 2024, then increased by 3.99% to $4.6 million in 2025.
  • Business Quant data shows Other Non-Current Assets for IMNM at $4.6 million in Q4 2025, $210000.0 in Q3 2025, and $200000.0 in Q2 2025.